Sinocelltech
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (34)
Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.
Started: 4/26/2024
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
Started: 1/8/2026
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Started: 12/29/2025
A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.
Started: 12/30/2025
A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years
Started: 12/26/2022
SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer
Started: 10/22/2019
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years
Started: 8/13/2023
Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A
Started: 1/21/2019
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Started: 5/1/2026
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Started: 12/16/2025
The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19
Started: 3/27/2021
A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years
Started: 4/1/2022
A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine
Started: 4/25/2022
A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine
Started: 1/5/2023
Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis
Started: 7/1/2024
To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19
Started: 3/28/2021
Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD
Started: 11/26/2024
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
Started: 6/23/2025
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Started: 2/1/2025
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine
Started: 2/6/2025
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
Started: 10/10/2024
A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies
Started: 2/28/2024
Phase I/II Study of SCTB39G in Advanced Solid Tumours
Started: 7/28/2025
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine
Started: 2/15/2025
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
Started: 1/1/2025
A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.
Started: 2/19/2025
A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma
Started: 4/1/2024
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.
Started: 4/30/2024
The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults
Started: 12/1/2021
A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19
Started: 1/15/2022
Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects
Started: 7/24/2020
Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.
Started: 5/1/2012
A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus
Started: 4/1/2026